[Federal Register Volume 67, Number 237 (Tuesday, December 10, 2002)]
[Notices]
[Page 75862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-31071]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated October 5, 2001, and published in the Federal 
Register on October 17, 2001 (66 FR 52781), B.I. Chemicals, Inc., which 
has changed its name to Boehringer Ingelheim Chemicals, Inc., 2820 N. 
Normandy Drive, Petersburg, Virginia 23805, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as an 
importer of phenylacetone (8501), a basic class of controlled substance 
listed in Schedule II.
    The firm plans to import the phenylacetone for the bulk manufacture 
of amphetamine.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 8923(a) and 
determined that the registration of Boehringer Ingelheim Chemicals, 
Inc. to import phenylacetone is consistent with the public interest and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Boehringer Ingelheim Chemicals, Inc. on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. These investigations have included inspection 
and testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to section 1008(a) of the Controlled Substance 
Import and Export Act and in accordance with title 21, Code of Federal 
Regulations, section 1301.34, the above firm is granted registration as 
an importer of the basic class of controlled substance listed above.

    Dated: November 5, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-31071 Filed 12-9-02; 8:45 am]
BILLING CODE 4410-09-M